However, murine models of H3.3-altered gliomas showed the accumulation of H3K27me3 marks at the p16ink4A promoter gene (CDKN2A), with a concomitant reduction in p16, supporting the notion that epigenetic mechanisms may play a role [26]. The gene discussed is CDKN2A; the disease is central nervous system cancer.